| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.091 | 0.05 |